NCT03985410View on ClinicalTrials.gov

Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

July 24, 2019

Study Completion Date

July 24, 2019

Conditions
Acinetobacter Baumannii-calcoaceticus Complex Infections
Interventions
DRUG

ETX2514

intravenous infusion

DRUG

Placebo

intravenous infusion

DRUG

moxifloxacin

oral tablet

Trial Locations (1)

21201

Pharmaron Clinical Pharmacology Center, Baltimore

Sponsors
All Listed Sponsors
lead

Entasis Therapeutics

INDUSTRY

NCT03985410 - Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers | Biotech Hunter | Biotech Hunter